The role of Chito-oligosaccharide in regulating ovarian germ stem cells function and restoring ovarian function in chemotherapy mice

Reprod Biol Endocrinol. 2021 Jan 25;19(1):14. doi: 10.1186/s12958-021-00699-z.

Abstract

In recent years, the discovery of ovarian germ stem cells (OGSCs) has provided a new research direction for the treatment of female infertility. The ovarian microenvironment affects the proliferation and differentiation of OGSCs, and immune cells and related cytokines are important components of the microenvironment. However, whether improving the ovarian microenvironment can regulate the proliferation of OGSCs and remodel ovarian function has not been reported. In this study, we chelated chito-oligosaccharide (COS) with fluorescein isothiocyanate (FITC) to track the distribution of COS in the body. COS was given to mice through the best route of administration, and the changes in ovarian and immune function were detected using assays of organ index, follicle counting, serum estrogen (E2) and anti-Mullerian hormone (AMH) levels, and the expression of IL-2 and TNF-α in the ovaries. We found that COS significantly increased the organ index of the ovary and immune organs, reduced the rate of follicular atresia, increased the levels of E2 and AMH hormones, and increased the protein expression of IL-2 and TNF-α in the ovary. Then, COS and OGSCs were co-cultured to observe the combination of COS and OGSCs, and measure the survival rate of OGSCs. With increasing time, the fluorescence intensity of cells gradually increased, and the cytokines IL-2 and TNF-α significantly promoted the proliferation of OGSCs. In conclusion, COS could significantly improve the ovarian and immune function of chemotherapy model mice, and improve the survival rate of OGSCs, which provided a preliminary blueprint for further exploring the mechanism of COS in protecting ovarian function.

Keywords: COS; Chemotherapy; Inflammation; OGSCs.

MeSH terms

  • Animals
  • Antineoplastic Agents / adverse effects
  • Cell Differentiation
  • Cell Proliferation
  • Cells, Cultured
  • Chitosan / pharmacokinetics
  • Disease Models, Animal
  • Female
  • Germ Cells / metabolism
  • Germ Cells / pathology
  • Germ Cells / physiology
  • Mice
  • Oligosaccharides / pharmacokinetics
  • Oligosaccharides / physiology*
  • Ovarian Follicle / metabolism
  • Ovarian Follicle / physiology
  • Ovary / metabolism
  • Ovary / pathology
  • Ovary / physiology*
  • Primary Ovarian Insufficiency / chemically induced
  • Primary Ovarian Insufficiency / pathology*
  • Recovery of Function
  • Stem Cells / metabolism
  • Stem Cells / pathology
  • Stem Cells / physiology*

Substances

  • Antineoplastic Agents
  • Oligosaccharides
  • oligochitosan
  • Chitosan